Bernadette Connaughton - Director at Halozyme Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
HALO on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Bernadette Connaughton - trading volume in the past year for Halozyme Therapeutics, Inc.

Holdings reported by Bernadette Connaughton for Halozyme Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 45K $3.4M $75.70 Oct 1, 2025 Direct
Option to Purchase Common Stock 5.75K May 1, 2025 Direct Common Stock

Transactions reported by Bernadette Connaughton for Halozyme Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.